PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8663906-0	1996	The direct reduction of cytochrome c by some anthraquinone antitumor compounds.	Anthraquinones	45-58	cytochrome c, somatic	Homo sapiens	24-36	
8663906-1	1996	The ability of various anthraquinone antitumor agents to undergo oxidative metabolism with concomitant cytochrome c reduction has been examined.	Anthraquinones	23-36	cytochrome c, somatic	Homo sapiens	103-115	
1324690-3	1992	This method is based on the ability of anthraquinones to decrease the amount of enzymatic cytochrome c reduction at low concentrations of NADH.	Anthraquinones	39-53	cytochrome c, somatic	Homo sapiens	90-102	
1324690-6	1992	On the other hand, the extent of the diminution of cytochrome c reduction by anthraquinones depended strongly on the structure of the compounds examined.	Anthraquinones	77-91	cytochrome c, somatic	Homo sapiens	51-63	
6251919-1	1980	It has been shown that during fast (< 1 ms) photosensitized by anthraquinone or benzophenone reduction of cytochrome c in 0.15 N NaOH water-glycerol solutions ferrocytochrome c in a nonequilibrium state with increased reactivity was formed.	Anthraquinones	66-79	cytochrome c, somatic	Homo sapiens	109-121	
31820379-13	2020	Immunoblot analysis carried out with apoptotic markers showed that cytochrome C and caspase-3 expression increased significantly in anthraquinone-treated cells, whereas 6-OHDA-treated group showed a significant decrease when compared with an experimental control group.	Anthraquinones	132-145	cytochrome c, somatic	Homo sapiens	67-79